Gene: YIF1A
Official Full Name: Yip1 interacting factor homolog A, membrane trafficking proteinprovided by HGNC
Gene Summary: Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Located in Golgi apparatus and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01574 | YIF1A Knockout cell line (HeLa) | Human | YIF1A | 1:3~1:6 | Negative | Online Inquiry |
KO01575 | YIF1A Knockout cell line (HCT 116) | Human | YIF1A | 1:2~1:4 | Negative | Online Inquiry |
KO01576 | YIF1A Knockout cell line (HEK293) | Human | YIF1A | 1:3~1:6 | Negative | Online Inquiry |
KO01577 | YIF1A Knockout cell line (A549) | Human | YIF1A | 1:3~1:4 | Negative | Online Inquiry |
YIF1A Gene Knockout Cell Lines are specially engineered mammalian cell lines that have undergone targeted genetic modification to disrupt the expression of the YIF1A gene. This gene encodes a protein that plays a crucial role in intracellular trafficking and protein processing in the endoplasmic reticulum. The knockout of YIF1A provides a powerful tool for researchers to study the physiological and pathological processes that are mediated by this gene and associated pathways. Through CRISPR-Cas9 technology and homologous recombination, these cell lines exhibit loss-of-function phenotypes that lend insight into cellular responses to stress and the dynamics of protein synthesis.
The primary function of YIF1A gene knockout is to elucidate its role in cellular mechanisms such as ER stress response, protein folding, and degradation, allowing researchers to understand how perturbations in these processes can lead to various diseases, including neurodegenerative disorders and cancer. In clinical settings, these cell lines can be instrumental in preclinical drug testing, where understanding the cellular response to therapeutic agents is critical.
One of the standout advantages of YIF1A Gene Knockout Cell Lines lies in their specificity and reliability for targeted studies, compared to conventional siRNA-mediated knockdown methods. Unlike transient knockdowns, these stable cell lines allow for long-term experiments and provide reproducible results, minimizing variability associated with transient expression systems. Furthermore, the ability to maintain physiological relevance makes these cell lines indispensable in translational research.
For researchers and clinicians aiming to comprehend the multifaceted roles of YIF1A in health and disease, these knockout cell lines offer an invaluable resource. They allow for rigorous investigation of gene function and drug interactions in controlled environments, ultimately paving the way for new therapeutic strategies.
At our company, we pride ourselves on our expertise in genetic engineering and cell line development. Our commitment to advancing research tools ensures that our YIF1A Gene Knockout Cell Lines are of the highest quality, backed by extensive validation, and tailored to meet the diverse needs of scientists globally.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.